Evidence map›Paper›PMID 31758793›Full record

ArticleBiostatistics (Oxford, England)2021

Dynamic landmark prediction for mixture data.

Tanya P Garcia, Layla Parast

Abstract read
In one paragraph

Article in Biostatistics (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tanya P GarciaDepartment of Statistics, Texas A&M University, 3143 TAMU, College Station, TX 77843-3143, USA and RAND Corporation, 1776 Main Street, Santa Monica, CA 90401, USA.
Layla ParastDepartment of Statistics, Texas A&M University, 3143 TAMU, College Station, TX 77843-3143, USA and RAND Corporation, 1776 Main Street, Santa Monica, CA 90401, USA.

Funding

Robust Statistical Methods to Identify and Use Surrogate Markers in DiabetesR01DK118354 · NIDDK · UNIVERSITY OF TEXAS AT AUSTIN · PI PARAST, LAYLA · 2018 to 2025
$2.0M
Innovative Statistical Models for Development of First Huntington's Disease Progression Risk Assessment ToolK01NS099343 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GARCIA, TANYA PAMELA · 2017 to 2019
$739k
Robust Statistical Methods to Identify Surrogate Markers in DiabetesR21DK103118 · NIDDK · RAND CORPORATION · PI PARAST, LAYLA · 2014 to 2015
$476k
NIDDK NIH HHS R01 DK118354NIDDK NIH HHS R21 DK103118NINDS NIH HHS K01 NS099343
6 · The paper itself

Abstract

In kin-cohort studies, clinicians want to provide their patients with the most current cumulative risk of death arising from a rare deleterious mutation. Estimating the cumulative risk is difficult when the genetic mutation status is unknown and only estimated probabilities of a patient having the mutation are available. We estimate the cumulative risk for this scenario using a novel nonparametric estimator that incorporates covariate information and dynamic landmark prediction. Our estimator has improved prediction accuracy over existing estimators that ignore covariate information. It is built within a dynamic landmark prediction framework whereby we can obtain personalized dynamic predictions over time. Compared to current standards, a simple transformation of our estimator provides more efficient estimates of marginal distribution functions in settings where patient-specific predictions are not the main goal. We show our estimator is unbiased and has more predictive accuracy compared to methods that ignore covariate information and landmarking. Applying our method to a Huntington disease study of mortality, we develop dynamic survival prediction curves incorporating gender and familial genetic information.

Indexed as

ProbabilityCohort StudiesHumansKin-cohort studyLandmark predictionMixture modelNonparametric risk prediction

Identifiers

PMID31758793
PMCPMC8286554

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.